Stefania Chiappetta

1.3k total citations
15 papers, 99 citations indexed

About

Stefania Chiappetta is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Stefania Chiappetta has authored 15 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 8 papers in Infectious Diseases and 4 papers in Emergency Medicine. Recurrent topics in Stefania Chiappetta's work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Stefania Chiappetta is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Stefania Chiappetta collaborates with scholars based in Italy, Japan and Belarus. Stefania Chiappetta's co-authors include Marco Ripa, Giuseppe Tambussi, Adriano Lazzarin, Silvia Nozza, Manuela Pogliaghi, Laura Galli, Mauro Malnati, Vincenzo Spagnuolo, Simone Pensieroso and Francesco Mazzotta and has published in prestigious journals such as PLoS ONE, Transplantation and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Stefania Chiappetta

14 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Chiappetta Italy 7 59 47 29 28 17 15 99
I. Chossat France 3 33 0.6× 65 1.4× 40 1.4× 54 1.9× 7 0.4× 4 152
Winai Ratanasuwan Thailand 8 125 2.1× 116 2.5× 34 1.2× 86 3.1× 25 1.5× 17 210
Stephen O’Farrell United Kingdom 4 37 0.6× 95 2.0× 41 1.4× 30 1.1× 17 1.0× 4 133
Ole Kirk Spain 5 49 0.8× 85 1.8× 25 0.9× 67 2.4× 4 0.2× 12 114
N. Atoui France 8 68 1.2× 59 1.3× 23 0.8× 46 1.6× 25 1.5× 11 165
Anja Hüfner Germany 8 80 1.4× 68 1.4× 17 0.6× 51 1.8× 45 2.6× 10 137
Akio Murakami-Ogasawara Mexico 5 55 0.9× 69 1.5× 26 0.9× 53 1.9× 19 1.1× 8 138
Silvia Odolini Italy 6 30 0.5× 49 1.0× 10 0.3× 55 2.0× 3 0.2× 14 99
Eileen Campbell United Kingdom 6 47 0.8× 51 1.1× 7 0.2× 52 1.9× 4 0.2× 10 114
M. Anne St. John Barbados 6 120 2.0× 51 1.1× 15 0.5× 31 1.1× 87 5.1× 8 151

Countries citing papers authored by Stefania Chiappetta

Since Specialization
Citations

This map shows the geographic impact of Stefania Chiappetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Chiappetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Chiappetta more than expected).

Fields of papers citing papers by Stefania Chiappetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Chiappetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Chiappetta. The network helps show where Stefania Chiappetta may publish in the future.

Co-authorship network of co-authors of Stefania Chiappetta

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Chiappetta. A scholar is included among the top collaborators of Stefania Chiappetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Chiappetta. Stefania Chiappetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pascale, Renato, Angelo Maccaro, Francesca Giovannenze, et al.. (2025). Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort study. Journal of Infection and Chemotherapy. 31(8). 102759–102759. 1 indexed citations
2.
Ripa, Marco, Stefania Chiappetta, Barbara Castiglioni, et al.. (2021). Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis. European Journal of Clinical Microbiology & Infectious Diseases. 40(6). 1319–1324. 1 indexed citations
3.
Merli, Marco, Claudia Alteri, Luna Colagrossi, et al.. (2021). Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection. Transplantation. 105(2). e22–e24.
4.
Ripa, Marco, Stefania Chiappetta, & Giuseppe Tambussi. (2017). Immunosenescence and hurdles in the clinical management of older HIV-patients. Virulence. 8(5). 508–528. 12 indexed citations
5.
Galli, Laura, Alba Bigoloni, Stefania Chiappetta, et al.. (2017). The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional study. Memórias do Instituto Oswaldo Cruz. 112(6). 452–455. 10 indexed citations
6.
Ripa, Marco, Manuela Pogliaghi, Stefania Chiappetta, et al.. (2016). Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up. Journal of Clinical Virology. 85. 86–89. 1 indexed citations
7.
Chiappetta, Stefania, Marco Ripa, Laura Galli, et al.. (2016). Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART. Journal of Antimicrobial Chemotherapy. 71(6). 1627–1631. 5 indexed citations
8.
Nozza, Silvia, Marco Ripa, Laura Galli, et al.. (2016). Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection. Journal of Antimicrobial Chemotherapy. 72(2). 632–633. 6 indexed citations
9.
Pogliaghi, Manuela, Marco Ripa, Simone Pensieroso, et al.. (2015). Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets. PLoS ONE. 10(10). e0140435–e0140435. 10 indexed citations
10.
Ripa, Marco, Manuela Pogliaghi, Stefania Chiappetta, et al.. (2015). Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial. Clinical Microbiology and Infection. 21(9). 876.e1–876.e4. 13 indexed citations
11.
Nozza, Silvia, Laura Galli, Andrea Antinori, et al.. (2014). Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study. Clinical Microbiology and Infection. 21(5). 510.e1–510.e9. 24 indexed citations
12.
Nozza, Silvia, Laura Galli, Alba Bigoloni, et al.. (2014). Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine.. PubMed. 37(2). 145–51. 6 indexed citations
13.
Chiappetta, Stefania, Manuela Pogliaghi, Marco Ripa, et al.. (2014). HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications. INFM-OAR (INFN Catania). 2014. 1–6. 2 indexed citations
14.
Ripa, Marco, Stefania Chiappetta, & Silvia Nozza. (2013). Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient. International Journal of STD & AIDS. 24(12). 980–982. 1 indexed citations
15.
Nozza, Silvia, Manuela Pogliaghi, Stefania Chiappetta, et al.. (2012). Levels of Soluble Endothelial Protein C Receptor Are Associated with CD4+ Changes in Maraviroc-Treated HIV-Infected Patients. PLoS ONE. 7(6). e37032–e37032. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Chossat Breakdown of academic impact, for papers by Winai Ratanasuwan Breakdown of academic impact, for papers by Stephen O’Farrell Breakdown of academic impact, for papers by Ole Kirk Breakdown of academic impact, for papers by N. Atoui Breakdown of academic impact, for papers by Anja Hüfner Breakdown of academic impact, for papers by Akio Murakami-Ogasawara Breakdown of academic impact, for papers by Silvia Odolini Breakdown of academic impact, for papers by Eileen Campbell Breakdown of academic impact, for papers by M. Anne St. John
Rankless by CCL
2026